Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome. 2020

Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science, Tabriz, Iran.

Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the spine and sacroiliac joints with unidentified etiology closely associated with metabolic syndrome (MetS). Recent studies have reported that immunological and oxidative stress factors are implicated in AS pathogenesis. The aim of this study was to investigate the oxidative and immunological factors in AS patients with or without MetS compare to control group. Real-Time PCR measured expression level of cytokines, transcription factors and related miRNAs. In addition, Th17 and Treg frequencies and cytokines secretion were evaluated by flowcytometry and ELISA methods, respectively. The oxidative stress biomarkers were also assessed with biochemical methods. In AS patients with MetS, higher Th17 and lower Treg frequency were observed. Increased levels of NF-kB and AP-1 mRNA expression were seen in AS patients with MetS (p = 0.0263 and p = 0.0104, respectively). MiR-146a and miR-223 were significantly decreased (p = 0.0005, p = 0.0161, respectively) and increase in miR-21 (p = 0.0002) was observed in AS patients with MetS compared to AS patients without MetS. Additionally, the secretion of TNF-α (p = 0.0167), IL-1β (p = 0.303), CCL2 (p = 0.0254), CCL3 (p = 0.0119), CXCL8 (p = 0.0364), adiponectin (p = 0.0183) and the levels of SOD (p = 0.0421), NO (p = 0.0451) and CAT (p = 0.0128) were increased in AS patients with MetS. We were not observed significant differences in TOS and GPX levels between studied groups. The higher levels of oxidative stress and immunological inflammatory markers in AS patients with MetS provide further evidences on the oxidative stress and immunological relationship in these patients.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013167 Spondylitis, Ankylosing A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions. Ankylosing Spondylitis,Bechterew Disease,Marie-Struempell Disease,Rheumatoid Spondylitis,Spondylarthritis Ankylopoietica,Ankylosing Spondylarthritis,Ankylosing Spondyloarthritis,Bechterew's Disease,Spondylitis Ankylopoietica,Spondyloarthritis Ankylopoietica,Ankylosing Spondylarthritides,Ankylosing Spondyloarthritides,Bechterews Disease,Marie Struempell Disease,Spondylarthritides, Ankylosing,Spondylarthritis, Ankylosing,Spondylitis, Rheumatoid,Spondyloarthritides, Ankylosing,Spondyloarthritis, Ankylosing
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
November 2011, Lupus,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
January 2014, BioMed research international,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
March 2016, European journal of rheumatology,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
November 1983, British journal of rheumatology,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
May 2007, Clinical rheumatology,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
February 1984, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
January 2009, Clinical and experimental rheumatology,
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
December 2012, Obesity (Silver Spring, Md.),
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
January 2018, Clinical and experimental hypertension (New York, N.Y. : 1993),
Alireza Pishgahi, and Rozita Abolhasan, and Shahla Danaii, and Bahareh Amanifar, and Mohammad Sadegh Soltani-Zangbar, and Majid Zamani, and Amin Kamrani, and Farzaneh Ghorbani, and Amir Mehdizadeh, and Hossein Samadi Kafil, and Farhad Jadidi-Niaragh, and Bahman Yousefi, and Mehrzad Hajialiloo, and Mehdi Yousefi
January 2024, Journal of medical biochemistry,
Copied contents to your clipboard!